Getting Coca-Cola to use cane sugar rather and ice cream manufacturers to stop their use of synthetic dyes are the latest ...

Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...

In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

Medicare wants to allow far more more surgeries to be done in outpatient facilities like ambulatory surgery centers.

The FDA is allowing Juul to keep its e-cigarettes on the market, providing relief to a company that has struggled for years ...

Elevance became the fourth major health insurer to lower or scrap its profit forecast, with the CFO call citing a ...

Researchers call for reform after a new study found U.S. preeclampsia guidelines lead to a high rate of false positives.

The opportunity to “ talk to a doctor now ” increases access to care, the drug companies say. But the legislators, and some ...

Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.

Today, senators uncover details about pharma deals with telehealth companies. Plus: More Medicare tech updates and a look at the drama between FDA and Whoop.

The people most at risk from suicide aren’t adolescents in angst or those experiencing a midlife lull, but men age 75 and ...